TCL Archive NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case October 7, 1977
TCL Archive Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied July 17, 1992
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983